21 U.S.C. § 399j: Abraham Accords Office

The Secretary, acting through the Commissioner of Food and Drugs, shall establish within the Food and Drug Administration an office, to be known as the Abraham Accords Office, to be headed by a director. select the location of the Abraham Accords Office in an Abraham Accords country; and establish such office; and assign to such office such personnel of the Food and Drug Administration as the Secretary determines necessary to carry out the functions of such office. as part of the Food and Drug Administration’s work to strengthen the international oversight of regulated commodities, provide technical assistance to regulatory partners in Abraham Accords countries on strengthening regulatory oversight and converging regulatory requirements for the oversight of regulated products, including good manufacturing practices and other issues relevant to manufacturing medical products that are regulated by the Food and Drug Administration; and facilitate interactions between the Food and Drug Administration and interested parties in Abraham Accords countries, including by sharing relevant information regarding United States regulatory pathways with such parties, and facilitate feedback on the research, development, and manufacturing of products regulated in accordance with this chapter; and carry out other functions and activities as the Secretary determines to be necessary to carry out this section. In this section, the term “Abraham Accords country” means a country identified by the Department of State as having signed the Abraham Accords Declaration. Nothing in this section shall be construed to require any action inconsistent with a national security recommendation provided by the Federal Government.